Maisto papildas Milanella Complex Zn, 30 kapsulių

Trumpai apie prekę

Prekė: Maisto papildas Milanella Complex Zn, 30 kapsulių. Kategorija: Vitaminų ir mineralų papildai.

• Gamintojas: NutroPharma
• Modelis: 5904161800286

Milanella complex Zn 30 kaps.

Nutropharma

Crapeseed lecithin

A mixture whose main ingredient is phospholipids, m.in. Phosphatidylcholine, which are natural components of human milk(3). The product uses deoiled powdered rapeseed lecithin, which contains a significant portion of valuable phospholipids in a small amount of raw material (deoiled lecithin)(4).

Bromelain

A natural mixture of enzymes derived from pineapple, which have the ability to digest proteins(5). It exhibits a number of properties, m.in. immunomodulatory and growth-restrictive microorganisms(6)(7).

Zinc

It contributes to the maintenance of normal fatty acid metabolism.

Scientific data:

• It has been proven that an adequate supply in the diet of m.in. zinc affects the synthesis of polyunsaturated fatty acids in erythrocyte phospholipids and milk(8)(9). This is what m.in means. for the physical properties of milk – reducing its viscosity and facilitating the outflow(2).

• During lactation, there may be a difficult outflow of milk and its retention in the milk ducts. There is a likelihood of growth of some bacteria (10).

• It is indicated that the use of lecithin affects the amount of polyunsaturated fatty acids in milk, and thus its viscosity and outflow from milk ducts(2).

• Rapeseed lecithin is characterized by a high content of polyunsaturated fatty acids (approx. 88%) and low content of saturated fatty acids (approx. 12%)(11).

• Oral intake of lecithin is recommended in the scheme of management of food retention in the milk ducts (Clinical Protocol of the Academy of Breastfeeding Medicine (ABM)(12), Recommendations of the Polish Society of Midwives(13)).

• In vitro studies show that bromelain has growth-restricting properties of certain bacteria(7).

• Increased growth of certain bacteria may be associated with difficult milk flow from the breast gland(12).

• The results of a pilot study indicate that the combined consumption of lecithin and bromelain contained in the product, together with lactic acid bacteria – L. salivarius SGL03, reduces breast tenderness in lactating women(1).

 

Developed on the basis of scientific data that do not constitute health claims. EU law prohibits the making of claims on the effects of bromelain and lecithin on human health. For this reason, we do not provide such health claims on the labelling of our products. We present the results of scientific research based on Articles 73 and 54 of the Constitution of the Republic of Poland.

 

 

1. Nehring-Gugulska M, Michalak E, Mińko A, Filipowicz N, Wietrak E. Use of natural ingredients (bromelain, lecithin, probiotic) as a complement to the management of breast milk flow disorders during lactation – a pilot study. Progress Neonatol. 2023;29(1).

2. Lauwers, J., Swisher A. Counseling the nursing mother: A lactation consultant’s guide. (5th ed. ) Sudbury (MA): Jones & Bartlett. 2011. 255, 396 – 397 p. Consumption of lecithin, a natural fat emulsifier, and limiting the amount of saturated fat in the diet helps women prevent recurrent clogging of milk ducts. Reducing lecithin intake can reduce the emulsification of fats in the maternal bloodstream and thus the ability of the breast to cleanse the milk ducts; Canadian Breastfeeding Foundation https://www.canadianbreastfeedingfoundation.org/basics/lecithin.shtml. Crowd. Canadian Breastfeeding Foundation: Lecithin is a dietary supplement that seems to help some mothers prevent their milk ducts from being blocked. It works by reducing the viscosity (density) of milk by increasing the amount of polyunsaturated fatty acids in milk.

3. Brink LR, Lönnerdal B. Milk fat globule membrane: the role of its various components in infant health and development. J Nutr Biochem [Internet]. 2020;85:108465. Available from: https://doi.org/10.1016/j.jnutbio.2020.108465. Crowd. The main role of MFGM (milk fat ball membranes) is to provide the baby with fatty acids. The delivery bubble contains polar lipids that allow the membrane to exist in an aqueous environment. The two dominant polar lipids are phospholipids (PL) and sphingolipids (SL); they are derived from mammary epithelial cells found in the mammary vesicles.

4. American Lecithin Company. Lecithins and phospholipids: a simple guide to use and selection. 2009;1–19. Available from: http://www.americanlecithin.com/lecithin_2009.pdf Lecithins contained in dietary supplements themselves have nutritional value. The phospholipids contained in them have been recognized by nutritionists and their beneficial effects have been proven in numerous clinical trials involving humans in relation to the liver, brain, heart and other organs. De-Oiled Lecithin – sum of phospholipids (PC, PE, PI, PA, small phospholipids) 73%, standard liquid lecithin (Standard Liquid Lecithin) – sum of phospholipids (PC, PE, PI, PA, small phospholipids) 46%; GRAS Notification-Canola Leci-thin (Nothin) The main element of the deoiling process is the concentration and purification of phospholipids, i.e. functional components.

5. AJ, Mitra S, Tallei TE, Tareq AM, Nainu F, Cicia D, et al. Bromelain a potential bioactive compound: A comprehensive overview from a pharmacological perspective. Life. 2021;11(4):1–26. Crowd. It is an authorised supportive agent (...) in the case of sinus and nasal oedema (...), reduces swelling in the nasal passages (...), Clinical studies indicate that the use of bromelain results in a reduction in bruising, pain and swelling (...), Reduces soft tissue swelling by 72,4% and pain (...), Bromelain acts as an antibacterial agent.

6. Rathnavelu V, Alitheen NB, Sohila S, Kanagesan S, Ramesh R. Potential roles of bromelain in clinical and therapeutic applications (Review). Biomed Reports. 2016;5(3):283–8. Crowd. There are numerous studies indicating the immunomodulatory effect of bromelain; Bromelain acts as an anti-adhesive agent through changes at receptor attachment sites.

7. Watters CM, Burton T, Kirui DK, Millenbaugh NJ. Enzymatic degradation of in vitro Staphylococcus aureus biofilms supplemented with human plasma. Infect Drug Resist. 2016;9:71–8. Crowd. Bromelain reduced biomass (Staphylococcus aureus) to 98%.

8. Barrera C, Valenzuela R, Chamorro R, Bascuñán K, Sandoval J, Sabag N, et al. The Impact of Maternal Diet during Pregnancy and Lactation on the Fatty Acid Composition of Erythrocytes and Breast Milk of Chilean Women. Nutr 2018, Vol 10, Page 839 [Internet]. 2018 Jun 28 [cited 2023 Oct 5];10(7):839. Available from: https://www.mdpi.com/2072-6643/10/7/839/htm Humans can synthesize AA and DHA, mainly in the liver, as a result of a complex metabolic process (...); the most important enzymes involved in these processes are desaturases ∆-5 and ∆-6. LCPUFA synthesis, as well as the availability of precursors and the activity of desaturaz ∆-5 and ∆-6 enzymes, is also dependent on the availability of specific nutrients such as zinc, magnesium, calcium, vitamin B6 and vitamin C. (...) reduced activity of desaturase ∆-5 and ∆-6 enzymes may adversely affect maternal DHA synthesis, reducing n-3 LCPUFA levels in macs.

9. Bichi E, Toral PG, Hervás G, Frutos P, Gómez-Cortés P, Juárez M, et al. Inhibition of ∆9-desaturase activity with sterculic acid: Effect on the endogenous synthesis of cis-9 18:1 and cis-9, trans-11 18:2 in dairy sheep. J Dairy Sci. 2012 Sep 1;95(9):5242–52. Pharmacological inhibitions of desaturase in sheep decreased the content of unsaturated fatty acids in milk, but the share of saturated fatty acids increased: crowd. (...) steric acid administration inhibits Δ9-desaturase by 70% based on cis-9 14:1 content in milk. This inhibition resulted in a decrease in the milk content of enzyme products (e.g. cis-9 10:1, cis-9 14:1, cis-9 16:1, cis-9 18:1 and cis-9, trans-11 18:2) and increase in substrate content (e.g. 14:0, 18:0 and trans-11 18:1), as well as a reduction in desaturase rates.

10. Fernández L, Cárdenas N, Arroyo R, Manzano S, Jiménez E, Martín V, et al. Prevention of Infectious Mastitis by Oral Administration of Lactobacillus salivarius PS2 during Late Pregnancy. Clin Infect Dis. 2016;62(5):568–73. Crowd. Breast glands are the habitat of many microorganisms in dynamic balance, including those that can cause breast inflammation. As a result of this imbalance, an infection may appear and general studies suggest that breast inflammation is associated with bacterial dysbiosis within the breast gland. Consumption of probiotic strains during late pregnancy and/or feeding increases levels of immunoglobulin A and transforming growth factor beta in milk, which can control local growth of bacteria that cause breast inflammation by limiting their ability to penetrate or damage the mammary epithelium.

11. Forging M. Properties and application of plant phosphatidylcholine in medicine, pharmacy and cosmetology. Cosmetology of Estet. 2018;7(1):29–35.

12. Mitchell KB, Johnson HM, Rodrá JM, Eglash A, Scherzinger C, Zakarija-grkovic I, et al. Academy of Breastfeeding Medicine Clinical Protocol #36: The Mastitis Spectrum, Revised 2022. 2022;17(5):360–76. Crowd. Sunflower or soy lecithin 5-10 g per day can be taken orally to reduce inflammation of the milk ducts and emulsify milk. Evidence levels: 1 – 3. The power of recommendation: C. (...) Recommendations for recurrent breast inflammation. Daily use of probiotics containing L. fermentum or, preferably, L. salivarius for preventive purposes should be considered, recognising the limitations resulting from the different efficacy of different strains of the same species. Common organisms in lactation mastitis include Staphylococcus (e.g., S. aureus, S. epidermidis, S. lugdunensis and S. hominis).

13. http://www.ptpol.pl/media/dopobrania/ZG_PTPol_rekomendacje_standard_porady_laktacyjnej_poloznej.pdf.

 

• Product Certificate: NQS, Eurofins, Poland Quality Award

• For BREASTFEEDING WOMEN
• Reduces breast tenderness1
• Reduces milk viscosity and facilitates milk flow2
• EFFECT CONFIRMED IN STUDY1

ACTIVE INGREDIENTS IN DAILY PORTION 6 capsules ZINC 10 mg 100% RAPESEED LECITHIN DEOILED POWDER 2 400 mg** BROMELAIN 2 500 GDU*** ** percentage of reference intake

*** GDU – gelatin digestion units

Ingredients: Deoiled rapeseed lecithin, powder, glazing agent: hydroxypropylcellulose; pineapple bromelain (Ananas comosus), anti-caking agents: magnesium salts of fatty acids, silicon dioxide; zinc gluconate.

WAY OF USE

Consume 2 capsules 3 times a day with a meal or according to the schedule recommended by your doctor/lactation specialist. The product should be used for 5 consecutive days. Do not exceed the recommended portion for consumption during the day. A dietary supplement cannot be used as a substitute for a varied diet.

Can be used together with Milanella biom dietary supplement, containing lactic acid bacteria Lactobacillus salivarius SGL03.

CONTRAINDICATIONS

Hypersensitivity to any of the ingredients of the preparation. The product is intended for adult women.

Specifications

Group	Name	Value
Parametry	Condition	new
Parametry	Invoice	With VAT invoice
Parametry	Manufacturer code	5904161800286
Parametry	Medical device	no
Parametry	Brand	NutroPharma
Parametry	Name	other (Milanella Complex)
Parametry	Form	capsules
Parametry	Number of pieces	30 pcs
Parametry	Volume	30 ml
Parametry	Basic ingredient	lecithin
Parametry	EAN (GTIN)	5904161800286
Parametry	Packaging status	original
Parametry	Expiration date	at least 1 year from the date of purchase
Parametry	For	for women,for pregnant women
Parametry	Additional features	safe for breastfeeding women,safe for pregnant women,pure (without additives)